MedTrace Logo

Intergenerational Behavioral Intervention to Enhance Physical Activity in Older Adults at Risk for Alzheimer's Disease

NCT06038643 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2025-07-09

Study results available
· View outcomes & findings →

Summary

This is a four-week pilot randomized controlled trial of a behavioral intervention in older adults at risk for Alzheimer's disease. Older participants are a subgroup from the PREVENT-AD longitudinal cohort. We will test whether a four-week intergenerational social motivation using a technology-based platform (intervention group) enhances physical activity relative to a control group.

Conditions

  • Physical Inactivity

Interventions

BEHAVIORAL

Motivational behavioural intervention and daily activities monitoring

Social motivation manipulation, self-transcendence daily messaging, and daily activities monitoring through accelerometry. Participants in this arm will have a study partner who receives daily feedback on the main participant's daily step count.

BEHAVIORAL

Active Control

Daily activities monitored through accelerometry.

Sponsors & Collaborators

  • Montreal Neurological Institute and Hospital

    collaborator OTHER

  • McGill University

    collaborator OTHER

  • National Institute on Aging (NIA)

    collaborator NIH

  • Douglas Mental Health University Institute

    lead OTHER

Principal Investigators

  • Maiya R Geddes, MD PhD · McGill University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-08
Primary Completion
2024-04-14
Completion
2024-05-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06038643 on ClinicalTrials.gov